• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东地区水痘的临床和经济负担:系统文献回顾。

The clinical and economic burden of varicella in the Middle East: a systematic literature review.

机构信息

Department of Pediatrics, Sheikh Khalifa Medical City, Abu Dhabi, UAE.

Child Healthcare Unit, Dubai Health Authority, Dubai, UAE.

出版信息

Hum Vaccin Immunother. 2020;16(1):21-32. doi: 10.1080/21645515.2019.1638726. Epub 2019 Sep 3.

DOI:10.1080/21645515.2019.1638726
PMID:31373864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7012098/
Abstract

This systematic literature review was conducted to better understand the epidemiology and burden of varicella across the Middle East, gain insight into the evidence to support using universal varicella vaccination (UVV), and identify potential data gaps. Both epidemiology and economic data on the burden of varicella were limited and varied significantly. Most of the data focussed on varicella burden in the absence of a UVV program. In the absence of UVV, varicella incidence is increasing across this region with varicella infection associated with substantial morbidity. Although limited, data on the impact of vaccination at a population level indicated UVV programs reduce varicella incidence and hospitalizations, in line with global experience. Further research and action are needed to better understand varicella epidemiology in the Middle East, increase awareness and understanding in the region, and provide local data to support national public-health decisions regarding the implementation of UVV programs.

摘要

本系统文献回顾旨在更好地了解中东地区的水痘流行病学和负担,深入了解支持使用通用水痘疫苗接种(UVV)的证据,并确定潜在的数据差距。水痘的流行病学和经济负担数据都很有限且差异很大。大多数数据都集中在没有 UVV 计划的情况下水痘负担。在没有 UVV 的情况下,该地区的水痘发病率正在上升,水痘感染与大量发病率有关。尽管数据有限,但在人群层面上接种疫苗的影响数据表明,UVV 计划可降低水痘发病率和住院率,与全球经验一致。需要进一步研究和采取行动,以更好地了解中东地区的水痘流行病学,提高该地区的认识和理解,并提供本地数据,以支持国家公共卫生决策,实施 UVV 计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/711f9bcd19ab/khvi-16-01-1638726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/234463305518/khvi-16-01-1638726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/ed91eec78356/khvi-16-01-1638726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/711f9bcd19ab/khvi-16-01-1638726-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/234463305518/khvi-16-01-1638726-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/ed91eec78356/khvi-16-01-1638726-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d807/7012098/711f9bcd19ab/khvi-16-01-1638726-g003.jpg

相似文献

1
The clinical and economic burden of varicella in the Middle East: a systematic literature review.中东地区水痘的临床和经济负担:系统文献回顾。
Hum Vaccin Immunother. 2020;16(1):21-32. doi: 10.1080/21645515.2019.1638726. Epub 2019 Sep 3.
2
Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review.拉丁美洲和加勒比地区的水痘负担:系统文献综述的结果。
BMC Public Health. 2019 May 8;19(1):528. doi: 10.1186/s12889-019-6795-0.
3
Burden of varicella in the Asia-Pacific region: a systematic literature review.亚太地区带状疱疹负担:系统文献回顾。
Expert Rev Vaccines. 2019 May;18(5):475-493. doi: 10.1080/14760584.2019.1594781. Epub 2019 Apr 14.
4
Health Impact and Cost-effectiveness Assessment for the Introduction of Universal Varicella Vaccination in Switzerland.瑞士推广水痘疫苗接种的健康影响和成本效益评估。
Pediatr Infect Dis J. 2021 Jun 1;40(6):e217-e221. doi: 10.1097/INF.0000000000003136.
5
Varicella vaccination in Italy and Germany - different routes to success: a systematic review.意大利和德国的水痘疫苗接种——不同的成功途径:系统评价。
Expert Rev Vaccines. 2020 Sep;19(9):843-869. doi: 10.1080/14760584.2020.1825947.
6
Burden of varicella in Central and Eastern Europe: findings from a systematic literature review.中东欧水痘负担:系统文献回顾的结果。
Expert Rev Vaccines. 2019 Mar;18(3):281-293. doi: 10.1080/14760584.2019.1573145. Epub 2019 Feb 27.
7
The impact of universal varicella vaccination on the clinical burden of varicella in Colombia: A National database Analysis, 2008-2019.水痘疫苗全覆盖对哥伦比亚水痘临床负担的影响:2008-2019 年全国数据库分析。
Vaccine. 2022 Aug 19;40(35):5095-5102. doi: 10.1016/j.vaccine.2022.07.012. Epub 2022 Jul 22.
8
Economic burden of varicella in Europe in the absence of universal varicella vaccination.欧洲未实施水痘疫苗普遍接种情况下的水痘经济负担。
BMC Public Health. 2021 Dec 21;21(1):2312. doi: 10.1186/s12889-021-12343-x.
9
Estimating the health economic impact of the universal varicella vaccination in Argentina from 2015 to 2019.估算 2015 年至 2019 年阿根廷水痘疫苗全民接种的卫生经济学影响。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2245703. doi: 10.1080/21645515.2023.2245703.
10
Implementing Universal Varicella Vaccination in Europe: The Path Forward.在欧洲实施普遍水痘疫苗接种:前进之路。
Pediatr Infect Dis J. 2019 Feb;38(2):181-188. doi: 10.1097/INF.0000000000002233.

引用本文的文献

1
Varicella-zoster virus seroprevalence among reproductive-age women in Iran: a meta-analysis and implications for targeted immunization.伊朗育龄妇女中水痘-带状疱疹病毒血清流行率:一项荟萃分析及对靶向免疫的启示
BMC Infect Dis. 2025 Aug 18;25(1):1029. doi: 10.1186/s12879-025-11415-2.
2
Seroprevalence of Varicella-Zoster Virus and the Need for Herpes Zoster Vaccination Among Adults in Saudi Arabia.沙特阿拉伯成年人中水痘-带状疱疹病毒血清阳性率及带状疱疹疫苗接种需求
Cureus. 2025 Mar 21;17(3):e80949. doi: 10.7759/cureus.80949. eCollection 2025 Mar.
3
Severe skin complications of varicella in previously healthy children in Iran: emerging concern.

本文引用的文献

1
Outbreak of varicella in preschool children despite one-dose vaccination.尽管接种了一剂水痘疫苗,学龄前儿童仍爆发水痘疫情。
Turk J Pediatr. 2018;60(1):56-62. doi: 10.24953/turkjped.2018.01.008.
2
Varicella infection in the Middle East: Prevalence, complications, and vaccination.中东地区的水痘感染:患病率、并发症及疫苗接种情况
J Res Med Sci. 2018 Apr 26;23:19. doi: 10.4103/jrms.JRMS_979_17. eCollection 2018.
3
Children Hospitalized for Varicella: Complications and Cost Burden.因水痘住院的儿童:并发症与成本负担
伊朗既往健康儿童水痘的严重皮肤并发症:新出现的问题。
BMC Infect Dis. 2025 Mar 24;25(1):402. doi: 10.1186/s12879-025-10794-w.
4
Silent reactivation of Varicella Zoster virus in hemodialysis patients.: A management dilemma.血液透析患者水痘带状疱疹病毒的无症状再激活:一个管理难题。
Saudi Med J. 2024 Dec;45(12):1391-1395. doi: 10.15537/smj.2024.45.12.20240553.
5
Atypical Presentation of Varicella-Zoster Virus Encephalitis: A Case Report.水痘-带状疱疹病毒脑炎的非典型表现:一例报告
Cureus. 2024 Sep 8;16(9):e68926. doi: 10.7759/cureus.68926. eCollection 2024 Sep.
6
Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024).医护人员对水痘带状疱疹病毒的免疫力:系统评价与荟萃分析(2024年)
Vaccines (Basel). 2024 Sep 6;12(9):1021. doi: 10.3390/vaccines12091021.
7
Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature.海湾合作委员会国家水痘带状疱疹病毒和带状疱疹病毒的流行病学:文献综述
Infect Dis Ther. 2023 Jan;12(1):81-93. doi: 10.1007/s40121-022-00715-8. Epub 2022 Dec 3.
8
Global varicella vaccination programs.全球水痘疫苗接种计划。
Clin Exp Pediatr. 2022 Dec;65(12):555-562. doi: 10.3345/cep.2021.01564. Epub 2022 Nov 2.
9
Clinical efficacy and effectiveness of alternative varicella vaccination strategies: An overview of reviews.替代水痘疫苗接种策略的临床疗效和效果:系统评价概述。
Rev Med Virol. 2023 Jan;33(1):e2407. doi: 10.1002/rmv.2407. Epub 2022 Nov 15.
10
Epidemiological health assessment in primary healthcare in the State of Qatar- 2019.卡塔尔国2019年初级医疗保健中的流行病学健康评估
Qatar Med J. 2021 Oct 25;2021(3):57. doi: 10.5339/qmj.2021.57. eCollection 2021.
Value Health Reg Issues. 2013 Sep-Oct;2(2):226-230. doi: 10.1016/j.vhri.2013.05.003. Epub 2013 Jul 23.
4
Varicella in Poland: economic burden in children 1-12 years of age in Poland, 2010-2015.波兰的水痘:2010-2015 年波兰 1-12 岁儿童的经济负担。
BMC Public Health. 2018 Mar 27;18(1):410. doi: 10.1186/s12889-018-5298-8.
5
Economic burden of varicella in children 1-12 years of age in Argentina, 2009-2014.2009 - 2014年阿根廷1至12岁儿童水痘的经济负担
J Med Econ. 2018 Apr;21(4):416-424. doi: 10.1080/13696998.2018.1431919. Epub 2018 Feb 7.
6
Cost-effectiveness of Varicella Vaccination Program in Iran.伊朗水痘疫苗接种计划的成本效益
Int J Prev Med. 2017 Dec 5;8:103. doi: 10.4103/ijpvm.IJPVM_295_16. eCollection 2017.
7
Varicella zoster virus-associated morbidity and mortality in Africa - a systematic review.非洲水痘带状疱疹病毒相关的发病率和死亡率——一项系统综述
BMC Infect Dis. 2017 Nov 14;17(1):717. doi: 10.1186/s12879-017-2815-9.
8
Economic burden of varicella in children 1-12 Years of age in Hungary, 2011-2015.2011 - 2015年匈牙利1至12岁儿童水痘的经济负担
BMC Infect Dis. 2017 Jul 14;17(1):495. doi: 10.1186/s12879-017-2575-6.
9
Varicella vaccination - the global experience.水痘疫苗——全球经验
Expert Rev Vaccines. 2017 Aug;16(8):833-843. doi: 10.1080/14760584.2017.1343669. Epub 2017 Jul 13.
10
A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.水痘带状疱疹病毒血清流行率的系统评价与荟萃分析:一项基于全国人群的研究。
J Clin Virol. 2017 Feb;87:49-59. doi: 10.1016/j.jcv.2016.12.001. Epub 2016 Dec 6.